December 6, 2024 | 12:00 PM ET
The webinar will discuss the optimal way to tailor treatment for Intermediate Risk Prostate Cancer Patients in the Era of Precision Medicine. More specifically, the role of androgen deprivation therapy and micro boosting will be discussed in details as well as how modern imaging and genomic analyses could be used for treatment intensification or de-escalation.
Faculty:
Pretesh Patel, MD, Assistant Professor and Vice Chair for Clinical Operations, Emory University
Lara Hathout, MD, Associate Professor and Director of Brachytherapy, Rutgers Cancer Institute
Irina Vergalasova, PhD, Associate professor and Director of Brachytherapy Physics, Rutgers Cancer Institute
Moderator:
Aurelie Garant, MD, Associate Professor and Director of Brachytherapy, UT Southwestern
Registration fees:
Members: Free
Non-Members: $45.00
